[go: up one dir, main page]

WO2007067757A3 - Certain chemical entities, compositions, and methods for modulating trpv1 - Google Patents

Certain chemical entities, compositions, and methods for modulating trpv1 Download PDF

Info

Publication number
WO2007067757A3
WO2007067757A3 PCT/US2006/047003 US2006047003W WO2007067757A3 WO 2007067757 A3 WO2007067757 A3 WO 2007067757A3 US 2006047003 W US2006047003 W US 2006047003W WO 2007067757 A3 WO2007067757 A3 WO 2007067757A3
Authority
WO
WIPO (PCT)
Prior art keywords
chemical entities
compositions
methods
certain chemical
trpv1
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2006/047003
Other languages
French (fr)
Other versions
WO2007067757A2 (en
Inventor
Jose S Mendoza
Carl Nicholas Hodge
John K Dickson Jr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Amphora Discovery Corp
Original Assignee
Amphora Discovery Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amphora Discovery Corp filed Critical Amphora Discovery Corp
Publication of WO2007067757A2 publication Critical patent/WO2007067757A2/en
Publication of WO2007067757A3 publication Critical patent/WO2007067757A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/62—Benzothiazoles
    • C07D277/64—Benzothiazoles with only hydrocarbon or substituted hydrocarbon radicals attached in position 2

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Provided are chemical entities chosen from compounds of Formula (I) and pharmaceutically or cosmetically acceptable salts, solvates, chelates, non-covalent complexes, prodrugs, and mixtures thereof. The chemical entities modulate TRPVl and are useful in the treatment of at least one disease or disorder modulated by TRPVl activity.
PCT/US2006/047003 2005-12-08 2006-12-05 Certain chemical entities, compositions, and methods for modulating trpv1 Ceased WO2007067757A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US74935105P 2005-12-08 2005-12-08
US60/749,351 2005-12-08

Publications (2)

Publication Number Publication Date
WO2007067757A2 WO2007067757A2 (en) 2007-06-14
WO2007067757A3 true WO2007067757A3 (en) 2008-01-31

Family

ID=38123536

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2006/047003 Ceased WO2007067757A2 (en) 2005-12-08 2006-12-05 Certain chemical entities, compositions, and methods for modulating trpv1

Country Status (1)

Country Link
WO (1) WO2007067757A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5643112B2 (en) 2008-01-28 2014-12-17 アモーレパシフィック コーポレイションＡｍｏｒｅｐａｃｉｆｉｃ Ｃｏｒｐｏｒａｔｉｏｎ Novel compounds as vanilloid receptors, isomers or pharmaceutically acceptable salts thereof, and pharmaceutical compositions containing the same
US8362012B2 (en) 2008-04-18 2013-01-29 Daewoong Pharmaceutical Co., Ltd. Benzoxazine benzimidazole derivative, a pharmaceutical composition comprising the same, and a use thereof
KR101621444B1 (en) 2008-07-02 2016-05-19 (주)아모레퍼시픽 Novel compounds, isomer thereof, or pharmaceutically acceptable salts thereof as vanilloid receptor antagonist and pharmaceutical compositions containing the same
KR101293384B1 (en) 2010-10-13 2013-08-05 주식회사 대웅제약 Novel pyridyl benzoxazine derivatives, pharmaceutical composition comprising the same, and use thereof

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004096784A1 (en) * 2003-04-28 2004-11-11 Astrazeneca Ab New heterocyclic amides exhibiting an inhibitory activity at the vanilloid receptor 1 (vr1).

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004096784A1 (en) * 2003-04-28 2004-11-11 Astrazeneca Ab New heterocyclic amides exhibiting an inhibitory activity at the vanilloid receptor 1 (vr1).

Also Published As

Publication number Publication date
WO2007067757A2 (en) 2007-06-14

Similar Documents

Publication Publication Date Title
WO2007067711A3 (en) Certain chemical entities, compositions, and methods for modulating trpv1
WO2005005378A3 (en) Indolinone hydrazides as c-met inhibitors
WO2005086661A3 (en) Compounds, pharmaceutical compositions and methods for use in treating metabolic disorders
WO2007024717A3 (en) Agents for preventing and treating disorders involving modulation of the ryr receptors
WO2005040116A3 (en) Indolinone derivatives and their use in treating disease-states such as cancer
WO2008062276A3 (en) Acetylene derivatives as stearoyl coa desaturase inhibitors
WO2004080377A3 (en) Kcnq channel modulating compounds and their pharmaceutical use
ATE540024T1 (en) ALLOSTERIC MODULATORS OF METABOTROPIC GLUTAMA RECEPTORS
TW200602036A (en) Diphenylazetidone derivates
NO20082145L (en) Prolinamide derivatives as sodium channel modulators
WO2005061452A8 (en) Diphenylazetidinone derivates possessing cholesterol absorption inhibitory activity
CY1112727T1 (en) CYCLUTOBUTYL PRODUCTS OF AMIN BENZOTHIJAZOLIS AND USE THESE AS PRESENTS OF HISTAMIN RECIPIENTS-3
DE602005017895D1 (en) PYRAZOLAMIDE DERIVATIVES, COMPOSITIONS AND METHODS OF APPLYING THESE COMPOUNDS
WO2007062999A3 (en) 1,5-substituted indol-2-yl amide derivatives
BR0316723A (en) Anilinopyrazole derivatives useful for the treatment of diabetes
WO2005086656A3 (en) Heteroarylaminopyrazole derivatives useful for the treatment of diabetes
ATE472529T1 (en) PROLINAMIDE DERIVATIVES AS SODIUM CHANNEL MODULATORS
WO2009037542A3 (en) Spirocyclic compounds as stearoyl coa desaturase inhibitors
MY148538A (en) Novel 2-azetidinone derivatives as cholesterol absorption inhibitors for the treatment of hyperlipidaemic conditions
ATE380816T1 (en) SUBSTITUTED IMIDAZOPYRIMIDINES FOR THE PREVENTION AND TREATMENT OF CANCER
NO20054787L (en) Indene derivatives as pharmaceuticals
WO2007131907A3 (en) 1h-indol-5-yl-piperazin-1-yl-methanone derivatives
MY138466A (en) Aminoalkoxyndoles as 5-ht6-receptor ligands for the treatment of cns-disorders
WO2007067757A3 (en) Certain chemical entities, compositions, and methods for modulating trpv1
WO2007067756A3 (en) Certain chemical entities, compositions, and methods for modulating trpv1

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 06845092

Country of ref document: EP

Kind code of ref document: A2